Changing Patterns of Lung Cancer Incidence by Histological Type

Cancer Epidemiology Biomarkers and Prevention

Volumn 1, Issue 1, 1991, Pages 29-34

  Devesa, Susan S ^a   Shaw, Gail L ^a   Blot, William J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; LUNG TUMOR; MALE; PATHOLOGY; RACE; REGISTER; SEX DIFFERENCE; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMAN; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGE; POPULATION SURVEILLANCE; RACIAL STOCKS; REGISTRIES; SEX FACTORS; UNITED STATES;

EID: 0026254615     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Devesa, S. S., Blot, W. J., and Fraumeni, J. F., Jr. Declining lung cancer among young men and women in the United States:a cohort analysis. J. Natl. Cancer Inst., 81:1568–1571, 1989.
2. Wu, A. H., Henderson, B. E., Thomas, D. C., et al. Secular trends in histologic types of lung cancer. J. Natl. Cancer Inst., 77:53–56, 1986.
3. Dodds, L., Davis, S., and Polissar, L. A population-based study of lung cancer incidence trends by histologic type, 1974–81. J. Natl. Cancer Inst., 76:21–29, 1986.
4. Beard, C. M., Jedd, M. B., Woolner, L. B., et al. Fifty-year trend in incidence rates of bronchogenic carcinoma by cell type in Olmstead County, Minnesota. J. Natl. Cancer Inst., 80:1404–1407, 1988.
5. Cutler, S. J., and Young, J. L., Jr. (eds.). Third national cancer survey:incidence data. Natl. Cancer Inst. Monogr., 41:1–454, 1975.
6. Young, J. L., Jr., Percy, C. L., and Asire, A. J. (eds.). Surveillance, epidemiology, end results:incidence and mortality data, 1973–77. Natl. Cancer Inst. Monogr., 57:1–1082, 1981.
7. Heston, J. F., Kelly, J. B., Meigs, J. W., et al. (eds.). Forty-five years of cancer incidence in Connecticut:1935–79. Natl. Cancer Inst. Monogr., 70:1–706, 1986.
8. Devesa, S. S., Horm, J. W., and Connelly, R. R. Trends in lung cancer incidence and mortality in the United States. In:M. Mizell and P. Correa (eds.), Lung Cancer:Causes and Prevention, pp. 33–45. Deerfield Beach, FL:Verlag Chemie, 1984.
9. Devesa, S. S., Silverman, D. T., Young, J. L., Jr., et al. Cancer incidence and mortality trends among whites in the United States, 1947–84. J. Natl. Cancer Inst., 79:701–770, 1987.
10. Percy, C. L., Berg, J. W., and Thomas, L. B. (eds.). Manual of Tumor Nomenclature and Coding. New York:American Cancer Society, 1968.
11. World Health Organization. International Classification of Diseases for Oncology. Geneva:WHO, 1976.
12. Ives, J. C., Buffler, P. A., and Greenberg, S. D. Environmental associations and histopathologic patterns of carcinoma of the lung:the challenge and dilemma in epidemiologic studies. Am. Rev. Respir. Dis., 128:195–209, 1983.
13. Johnston, W. W. Cytologic diagnosis of lung cancer-principles and problems. Pathol. Res. Pract., 181:1–36, 1986.
14. Watkin, S. W. Temporal demographic and epidemiologic variation in histologic subtypes of lung cancer:a literature review. Lung Cancer, 5:69–81, 1989.
15. Lundgren, R., Bergman, F., and Angstrom, T. Comparison of trans-bronchial fine needle aspiration biopsy, aspiration of bronchial secretion, bronchial washing, brush biopsy and forceps biopsy in the diagnosis of lung cancer. Eur. J. Respir. Dis., 64:378–385, 1983.
16. Minna, J. D., Pass, H., Glatstein, E., et al. Cancer of the lung. In:V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer:Principles and Practice of Oncology, Ed. 3, pp. 591–705. Philadelphia:J. B. Lippincott Co., 1989.
17. Said, J. W., Vimadalal, S., Nash, G., et al. Immunoreactive neuron-specific enolase, bombesin, and chromagranin as markers for neuroendocrine lung tumors. Hum. Pathol., 16:236–240, 1985.
18. Yesner, R., and Carter, D. Pathology of carcinoma of the lung:changing patterns. Clin. Chest Med., 3:257–289, 1982.
19. Yesner, R., Gelfman, N. A., and Feinstein, A. R. A reappraisal of histopathology in lung cancer and correlation of cell types with antecedent cigarette smoking. Am. Rev. Respir. Dis., 107:790–797, 1973.
20. Trump, B. F., McDowell, E. M., and Harris, C. C. Chemical carcinogenesis in the tracheobronchial epithelium. Environ. Health Perspect., 55:77–84, 1984.
21. Butler, C., Samet, J. M., Humble, C. G., et al. Histopathology of lung cancer in New Mexico, 1970–72 and 1980–81. J. Natl. Cancer Inst., 78:85–90, 1987.
22. U.S. Department of Health and Human Services. The Health Consequences of Smoking:Cancer. A Report of the Surgeon General, DHHS Publication (PHS) 82–50179. Rockville, MD:Office on Smoking and Health, 1982.
23. International Agency for Research on Cancer. Evaluation of the Carcinogenic Risk of Chemicals to Humans:Tobacco Smoking, Vol. 38. Lyon, France:International Agency for Research on Cancer, 1986.
24. Harris, J. E. Cigarette smoking among successive birth cohorts of men and women in the United States during 1900–80. J. Natl. Cancer Inst., 71:473–479, 1983.
25. Lubin, J. H., and Blot, W. J. Assessment of lung cancer risk factors by histologic type. J. Natl. Cancer Inst., 73:383–389, 1984.
26. Higgins, I. T., and Wynder, E. L. Reduction in risk of lung cancer among ex-smokers with particular reference to histologic type. Cancer (Phila.), 62:2397–2401, 1988.
27. Stayner, L. T., and Wegman, D. H. Smoking, occupation, and histopathology of lung cancer:a case-control study with the use of the Third National Cancer Survey. J. Natl. Cancer Inst., 70:421–426, 1982.
28. Pasternak, B. S., Shore, R. E., and Albert, R. E. Occupational exposure to chloromethyl ethers. J. Occup. Med., 19:741–746, 1977.
29. Samet, J. M. Radon and lung cancer. J. Natl. Cancer Inst., 81:745–757, 1989.
30. Hoover, R., and Fraumeni, J. F., Jr. Risk of cancer in renal-transplant recipients. Lancet, 2:55–57, 1973.
31. Fraumeni, J. F., Jr., Wertelecki, W., Blattner, W. A., et al. Varied manifestations of a familial lymphoproliferative disorder. Am. J. Med., 59:145–151, 1975.
32. Gao, Y. T., Blot, W. J., Zheng, W., et al. Lung cancer among Chinese women. Int. J. Cancer, 40:604–609, 1987.
33. Beattie, C. W., Hansen, N. W., and Thomas, P. A. Steroid receptors in human lung cancer. Cancer Res., 45:4206–4214, 1985.
34. Mulvihill, J. J. Host factors in human lung tumors:an example of ecogenetics in oncology. J. Natl. Cancer Inst., 57:3–7, 1976.
35. Ziegler, R. G. Vegetables, fruits, and carotenoids and the risk of cancer. Am. J. Clin. Nutr., 53:2515–2595, 1991.
36. Greenberg, E. R., Korson, R., Baker, J., et al. Incidence of lung cancer by cell type:a population-based study in New Hampshire and Vermont. j. Natl. Canter Inst., 72:599–603, 1984.
37. Anton-Culver, H., Culver, B. D., Kurosaki, T., et al. Incidence of lung cancer by histological type from a population-based registry. Cancer Res., 48. 6580–6583, 1988.
38. Ernster, V. L., Selvin, S., Sacks, S. T., et al. Major histologic types of cancers of the gum and mouth, esophagus, larynx, and lung by sex and by income level. J. NaIl. Caner Inst., 69:773–776, 1982.
39. Yang, C. P., Gallagher, R. P., Weiss, N. S., et al. Differences in incidence rates of cancers of the respiratory tract by anatomic subsite and histologic type: an etiologic inlplication. J. Natl. Cancer Inst., 81:1828–1831, 1989.